Cargando…

A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China

BACKGROUND: Acute myeloid leukemia (AML) is a common type of hematological malignancy in elderly people. Geriatricians have developed comprehensive geriatric assessment (CGA) methods for elderly patients; however, the tools used for CGA in AML are not uniform. Thus, we aimed to validate the instrume...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chun-Li, Feng, Ru, Li, Jiang-Tao, Wang, Ting, Bai, Jie-Fei, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046252/
https://www.ncbi.nlm.nih.gov/pubmed/31934939
http://dx.doi.org/10.1097/CM9.0000000000000645
_version_ 1783501930818961408
author Zhang, Chun-Li
Feng, Ru
Li, Jiang-Tao
Wang, Ting
Bai, Jie-Fei
Liu, Hui
author_facet Zhang, Chun-Li
Feng, Ru
Li, Jiang-Tao
Wang, Ting
Bai, Jie-Fei
Liu, Hui
author_sort Zhang, Chun-Li
collection PubMed
description BACKGROUND: Acute myeloid leukemia (AML) is a common type of hematological malignancy in elderly people. Geriatricians have developed comprehensive geriatric assessment (CGA) methods for elderly patients; however, the tools used for CGA in AML are not uniform. Thus, we aimed to validate the instrumental activities of daily living (IADL) scales, age, comorbidities (Charlson Comorbidity Index), and albumin (IACA) index, which is a new tool for CGA, in elderly patients with AML. METHODS: Patients aged ≥60 years who had been diagnosed with AML were screened for eligibility. Among the IACA low-, intermediate-, and high-risk groups, continuous variables were compared using the Mann-Whitney U test, and categorical variables were compared using χ(2) and Fisher exact tests. In addition, probabilities of overall survival (OS) were estimated using the Kaplan-Meier method. RESULTS: A total of 21, 34, and 6 patients were categorized into IACA low-risk (0 point), intermediate-risk (1–2 points), and high-risk (≥3 points) groups, respectively. The rates of relapse/progression-related mortality were 23.8%, 58.8%, and 100.0% in the IACA low-, intermediate-, and high-risk groups, respectively (χ(2) = 12.81, P < 0.001). The 2-year probabilities of OS were 47.7% (95% confidence interval [CI] 22.8%–72.6%) and 20.2% (95% CI 5.9%–34.5%) in the IACA low- and intermediate-risk groups, respectively (χ(2) = 5.99, P = 0.014), which were significantly higher than those in the high-risk group (low-risk [47.7% (95% CI 22.8%–72.6%)] vs. high-risk [0], χ(2) = 20.80, P < 0.001; intermediate-risk [20.2% (95% CI 5.9%–34.5%)] vs. high-risk [0], χ(2) = 7.56, P = 0.006; respectively). In the IACA low-risk group, the 2-year probability of OS in patients receiving induction chemotherapy (50.8% [95% CI 24.1%–77.5%]) was significantly higher than that in those receiving best supportive care (0, χ(2) = 25.74, P < 0.001). CONCLUSION: We suggest that the IACA index might be a simple and effective tool for comprehensive geriatric assessment in elderly AML patients.
format Online
Article
Text
id pubmed-7046252
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70462522020-03-10 A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China Zhang, Chun-Li Feng, Ru Li, Jiang-Tao Wang, Ting Bai, Jie-Fei Liu, Hui Chin Med J (Engl) Original Articles BACKGROUND: Acute myeloid leukemia (AML) is a common type of hematological malignancy in elderly people. Geriatricians have developed comprehensive geriatric assessment (CGA) methods for elderly patients; however, the tools used for CGA in AML are not uniform. Thus, we aimed to validate the instrumental activities of daily living (IADL) scales, age, comorbidities (Charlson Comorbidity Index), and albumin (IACA) index, which is a new tool for CGA, in elderly patients with AML. METHODS: Patients aged ≥60 years who had been diagnosed with AML were screened for eligibility. Among the IACA low-, intermediate-, and high-risk groups, continuous variables were compared using the Mann-Whitney U test, and categorical variables were compared using χ(2) and Fisher exact tests. In addition, probabilities of overall survival (OS) were estimated using the Kaplan-Meier method. RESULTS: A total of 21, 34, and 6 patients were categorized into IACA low-risk (0 point), intermediate-risk (1–2 points), and high-risk (≥3 points) groups, respectively. The rates of relapse/progression-related mortality were 23.8%, 58.8%, and 100.0% in the IACA low-, intermediate-, and high-risk groups, respectively (χ(2) = 12.81, P < 0.001). The 2-year probabilities of OS were 47.7% (95% confidence interval [CI] 22.8%–72.6%) and 20.2% (95% CI 5.9%–34.5%) in the IACA low- and intermediate-risk groups, respectively (χ(2) = 5.99, P = 0.014), which were significantly higher than those in the high-risk group (low-risk [47.7% (95% CI 22.8%–72.6%)] vs. high-risk [0], χ(2) = 20.80, P < 0.001; intermediate-risk [20.2% (95% CI 5.9%–34.5%)] vs. high-risk [0], χ(2) = 7.56, P = 0.006; respectively). In the IACA low-risk group, the 2-year probability of OS in patients receiving induction chemotherapy (50.8% [95% CI 24.1%–77.5%]) was significantly higher than that in those receiving best supportive care (0, χ(2) = 25.74, P < 0.001). CONCLUSION: We suggest that the IACA index might be a simple and effective tool for comprehensive geriatric assessment in elderly AML patients. Wolters Kluwer Health 2020-02-20 2020-02-20 /pmc/articles/PMC7046252/ /pubmed/31934939 http://dx.doi.org/10.1097/CM9.0000000000000645 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Zhang, Chun-Li
Feng, Ru
Li, Jiang-Tao
Wang, Ting
Bai, Jie-Fei
Liu, Hui
A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
title A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
title_full A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
title_fullStr A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
title_full_unstemmed A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
title_short A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
title_sort new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from china
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046252/
https://www.ncbi.nlm.nih.gov/pubmed/31934939
http://dx.doi.org/10.1097/CM9.0000000000000645
work_keys_str_mv AT zhangchunli anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT fengru anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT lijiangtao anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT wangting anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT baijiefei anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT liuhui anewtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT zhangchunli newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT fengru newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT lijiangtao newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT wangting newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT baijiefei newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina
AT liuhui newtoolforcomprehensivegeriatricassessmentinelderlypatientswithacutemyeloidleukemiaapilotstudyfromchina